FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on ...

Little Green Pharma Ltd. (AU:LGP) has released an update. Little Green Pharma Ltd. is hosting an investor webinar where CEO Paul Long will present the Quarterly Activities Report for September 2024.

This move will significantly enhance the company's ability to advance the use of proteomics as a vital tool for the pharmaceutical and biotech industries. Building on recent strategic initiatives ...

Firebrick Pharma Limited (AU:FRE) has released an update. Firebrick Pharma Limited has made significant strides with its nasal spray, Nasodine, by securing a local manufacturing agreement in the ...

A pharmaceutical body has warned of potential shortages of some medicines in Northern Ireland unless there is a delay to the implementation of the Windsor Framework. The framework is the post ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

Shares of Longboard Pharmaceuticals Inc. are surging more than 51% Monday, boosted by H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical company.

H. Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases. The Danish pharmaceutical company is offering ...

How are you going to win a dozen?" he added. In 2021, the Sackler family, owners of Purdue Pharma, reached a settlement deal in bankruptcy court to pay billions of dollars and stop making opioids.

(Bloomberg) -- Cycle Pharmaceuticals Ltd. is still interested in acquiring Vanda Pharmaceuticals Inc. after one of Vanda’s drugs failed to receive regulatory approval. Cambridge, UK-based Cycle ...